Investor's Business Daily on MSN
Pfizer ducks continued COVID fallout as hard-fought obesity readout looms
Pfizer beat second-quarter expectations Tuesday, offsetting a continued steep decline for its Covid products. But Pfizer stock fell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results